Language-population | Year | Sample size | Sample size calculation | Consecutive or not | Time interval of test–retest reliability |
---|---|---|---|---|---|
1999/2003/2006 | 261 CPPS/151 CP, 149 BPH, 134 healthy controls/ 174 CP/CPPS/a randomly selected cohort of white men 47 to 90Â years old | No/No/No/No | No/No/No/No | 1Â month/ 6Â weeks | |
Original-Australian [12] | 2009 | Australian men aged 16–64 years | No | No | NA |
Original-Malaysian [13] | 2006 | 47 CP/CPPS, 20 BPH, 13 healthy controls | No | No | NA |
Original-Spanish [14] | 2001 | 37 CP | No | No | NA |
Arabic-Egyptian [22] | 2006 | 30 CPPS, 48 healthy controls | No | Yes | 1Â week |
Chinese-Mainland [23] | 2010 | 162 CP, 97 healthy controls | No | Yes | 4–6 h |
Chinese-Malaysian [13] | 2006 | 32 CP/CPPS, 43 BPH, 72 healthy controls | No | No | Short-term test–retest was evaluated 1 week later, long-term 14 weeks later |
Danish [24] | 2019 | 112 CP/CPPS | No | No | Four days |
Estonian [25] | 2006 | 64 CP/CPPS, 73 controls without CP/CPPS | No | No | NA |
Finnish [26] | 2003 | 155 CPPS, 12 controls had no previous urological history | No | Yes |  < 1 week later |
French-Canadian [27] | 2005 | 36 CP/CPPS, 38 controls presented for pre-vasectomy consultation | No | Yes | 14Â days |
2001, 2004 | 137 patients with CP/CPPS NIH type III | No | Yes | NA | |
Italian [30] | 2005 | 42 CPPS, 81 healthy controls | No | No | 1Â week later |
Japanese (a) [31] | 2002 | 34 patients with CP/CPPS NIH type III, 35 BPH, 18 controls | No | No | NA |
Japanese (b) [32] | 2002 | 103 CP, 60 BPH, 87 healthy controls | No | No | 2Â weeks |
Malaysian [13] | 2006 | 21 CP/CPPS, 8 BPH, 12 healthy controls | No | No | Short-term test–retest was evaluated 1 week later, long-term 14 weeks later |
Persian [33] | 2020 | 42 CP/CPPS, 38 healthy controls | No | Yes | 1Â week |
Portuguese-Brazilian [34] | 2013 | 30 CPPS | No | Yes | 1 h |
Spanish [14] | 2001 | 37 CP | No | Yes | NA |
Turkish [35] | 2020 | 116 CP/CPPS, 88 healthy controls | No | No | 2Â weeks |